Is Glycosylated Hemoglobin A1c a Surrogate for Metabolic Syndrome in Nondiabetic, First-Degree Relatives of African-American Patients with Type 2 Diabetes?

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 10, 2003, Pages 4596-4601

  Osei, Kwame ^a,b   Rhinesmith, Scott ^a   Gaillard, Trudy ^a   Schuster, Dara ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b 491 McCampbell Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BODY WEIGHT; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; FEMALE; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SIBLING; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN AMERICANS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INCIDENCE; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS;

EID: 0242288741     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030686     Document Type: Article

References (60)

1. Reaven GM 1988 Role of insulin resistance in human disease. Diabetes 37: 1595-1607
2. Manolio TA, Savage PJ, Burge GL, Liu KA, Wagenknecht LE, Sidney S, Jacobs Jr DR, Roseman JM, Donahue RP, Oberman A 1990 Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA Study. Arteriosclerosis 10:430-436
3. Ferrannini E, Haffner SM, Mitchell BD, 1991 Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422
4. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP 1992 Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722
5. Hedblad B, Nilsson P, Engstrom G, Berglund G, Janzon L 2002 Insulin resistance in non-diabetic subject is associated with increased with increased incidence of myocardial infarction and death. Diabet Med 19:470-475
6. DeFronzo RA, Ferrannini E 1991 Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
7. Benjamin SM, Valdez R, Geiss L, Rolka DB, Narayan KM 2003 Estimated number of adults with prediabetes in the USA in 2000. Opportunities for prevention. Diabetes Care 26:645-649
8. Goff DC, Zaccaro DJ, Haffner SM, Saad MF 2003 Insulin sensitivity and the risk of incident hypertension. Insights from the Insulin Resistance Atherosclerosis Study. Diabetes Care 26:805-809
9. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, Howard BV 2003 Insulin resistance, the metabolic syndrome and risk of incident cardiovascular disease in nondiabetic American Indians. The Strong Heart Study. Diabetes Care 26:861-867
10. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutritional Examination Survey. JAMA 287:356-359
11. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB 2002 The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutritional Examination Survey, 1998-1994. Arch Intern Med 163:427-436
12. Cleeman JI, LeFant C 1998 The National Cholesterol Program: progress and prospects. JAMA 280:2059-2060
13. Boomgarden ZT 2003 Americans Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome. Diabetes Care 26:933-939
14. Stratton IM, Adler AI, Neil AW, Turner R 2000 Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS, 35): prospective observational study. Br Med J 321: M405-M412
15. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications on insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
16. Peters AL, Davidson MB, Schiger DL, Hasselbald V 1996 A clinical approach for the diagnosis of diabetes mellitus; an analysis using glycosylated hemoglobin levels. Meta-Analysis Research Group on Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 276:1246-1252
17. Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flagel KM, Ebberhardt MS, Goldstein DE 2000 Use of GHb (HbA1c) in screening of undiagnosed diabetes in the US population. Diabetes Care 23: 187-191
18. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE 2002 Defining the relationship between plasma glucose and HbA1c: analysis of glucose and HbA1c I in the Diabetes Control and Complications Trial. Diabetes Care 25:275-285
19. Monnier L, Lapinski H, Colete C 2003 Contributions of fasting and post-prandial plasma glucose increments to overall diurnal hyperglycemia of type 2 diabetic patients. Variations with increasing levels of HbA1c. Diabetes Care 26:881-883
20. Saadine JB, Fagot-Champagne A, Rolka D, Narayan KM, Geiss L, Eberhardt M, Fiegel KM 2002 Distribution of HbA1c levels for children and young adults in the U. S. Third National Health and Nutrition Examination. Diabetes Care 25:1326-1330
21. Yates AP, Laing I 2002 Age-related increase in hemoglobin A1c and fasting plasma glucose in accomplished by a decrease in β-cell function without change in insulin sensitivity: evidence from cross-sectional of hospital personnel. Diabet Med 19:254-258
22. Diabetes Prevention Program Research Group 2002 Reduction in the incident of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:303-403
23. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
24. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV 1997 Effects of diet and exercise in the prevention of NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544
25. Osei K 1990 Predicting type II diabetes in persons at risk. Ann Intern Med 113:905-907
26. King H, Rewers M 1993 Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177
27. King H, Aubert R, Herman WH 1998 Global burden of diabetes, 1995-2025. Prevalence and numerical estimates and projections. Diabetes Care 21:1414-1433
28. Harris MI, Flegal KM, Cowie C, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD 1998 Prevalence of diabetes, impaired fasting and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Survey 1988-1994. Diabetes Care 21:518-524
29. Harris MI, Klein RD, Cowie CC, Rowland M, Byrd-Holt DD 1998 Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A US population study. Diabetes Care 21:1230-1235
30. Osei K, Gaillard T, Schuster DID 1997 Pathogenetic mechanism of impaired glucose tolerance and type 2 diabetes in African Americans. The significance of insulin secretion, insulin sensitivity and glucose effectiveness. Diabetes Care 20:396-404
31. Osei K, Schuster DIP 1996 Decreased insulin-mediated but not non-insulin dependent glucose disposal in glucose intolerance and type 2 diabetes in Africa (Ghanaian) immigrants. Am J Med Sci 311:113-121
32. Brancati LB, Kao WH, Folsom AB, Watson RL, Szklo M 2000 Incident type 2 diabetes mellitus in African American and white adults. The Atherosclerosis Risk in Communities Study. JAMA 283:2253-2259
33. Haffner S, Howard R, Mayer B, Bergman RN, Savage PJ, Rewers M. Mykkinen L, Karter AJ, Hamman R, Saad ME 1997 Insulin sensitivity and acute insulin responses in African Americans, non-Hispanic whites and Hispanics and NIDDM: The Insulin Resistance and Atherosclerosis Study. Diabetes 46: 63-69
34. Osei K, Schuster DP 1994 Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in black and white Americans. Diabet Med 11: 755-762
35. Osei K, Cottrell DA 1994 Minimal model analyses of insulin sensitivity and glucose dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes. Eur J Clin Invest 24:843-850
36. Haffner SM, D'Agistnio R, Saad MF, Rewers M, Mykinnen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN 1996 Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45: 742-747
37. Arslanian S, Suprasongsin C 1996 Differences in the in vivo insulin secretion and sensitivity in healthy blacks versus white adolescents. J Pediatr 129:440-443
38. Schuster DP, Kien CIL, Osei K 1998 Differential impact of obesity on glucose metabolism in black and white adolescents. Am J Med Sci:361-367
39. Young-Hyman D, Schulendt DG, Herman L, Luca FD, Counte D 2001 Evaluation of the insulin resistance syndrome in 5-10 year old overweight/obese African-American children. Diabetes Care 24:1359-1364
40. Goran MI, Cruz ML, Bergman RN 2002 Watanabe R Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 25:2184-2190
41. World Health Organization Study Group 1985 Diabetes mellitus: report of WHO Study Group. WHO Technical Report Series Number 7727:88
42. 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
43. Segal KR, Loan MC, Fitzgerald PL, Hodgdon JA, Van Itallie TB 1988 Lean body mass estimation by bioelectrical impedance analysis; a four-site cross-validation study. Am J Clin Nutr 47:4-17
44. 1997 The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2446
45. Bergman RN 1989 Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes 336:1512-1527
46. Finegood DT, Hramiak IM, Dupre J 1990 A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics inpatients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538-1549
47. Mathews DR, Hosker JP, Rudenski AS, Taylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
48. Osei K, Schuster DP 1996 Effects of race and ethnicity on insulin sensitivity, blood pressure, and heart rate in 3 ethnic populations; comparative studies in African-Americans, African immigrants (Ghanaians), and white Americans using ambulatory blood pressure monitoring. Am J Hypertens 9:1157-1164
49. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, DeGregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C 1991 Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733-739
50. Metcalf PA, Sharrett AR, Folsom AR, Duncan BB, Patsch W, Hutchinson RG, Szklo M, Davis CE, Tyroler HA 1998 African American-white differences in lipids, lipoproteins and apolipoprotein, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 148:750-760
51. Osei K, Gaillard T, Schuster DP 1999 Cardiovascular risk factors in African Americans with varying degrees of glucose intolerance. Diabetes Care 22: 1588-1590
52. Cowie CC, Howard BV, Harris MI 1991 Serum lipoproteins in African Americans and whites with non-insulin-dependent diabetes in the US population. Circulation 91:1185-1191
53. Fontbonne A, Papoz L, Eschwege E, Roger M, Saint-Paul M, Simon D 1992 Features of insulin resistance syndrome in men from French Caribbean Islands. The Telecom Study. Diabetes 41:1385-1389
54. Martin BC, Warram JH, Ronser B, Rich SS, Soeldner JS, Krowlewski AS 1992 Familial clustering of insulin sensitivity. Diabetes 41:850-854
55. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WGH, Knowler WC, Bennett PH, Moll P, Bogardus C 1987 In vivo insulin action is a familial characteristic in nondiabetic Pima Indians. Diabetes 36:1329-1335
56. Martin BC, Warram JH, Krowleski AS, Bergman RW, Soeldner JS, Kahn CR 1992 Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a follow-up study. Lancet 340:925-929
57. Vaag A, Henrikson JE, Madsbad S, Holm N, Beck-Nielsen H 1995 Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin dependent mellitus. J Clin Invest 95:690-698
58. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L 1989 Early metabolic defects in persons at increased risk for noninsulin-dependent diabetes mellitus. N Engl J Med 321:337-343
59. Osei K, Cottrell DA, Orabella MM 1991 Insulin sensitivity, glucose effectiveness and body fat distribution patterns in nondiabetic offspring of patients with noninsulin-dependent diabetes mellitus (NIDDM). Diabetes Care 14: 890-896
60. Hogan P, Dall T, Nikolov P 2003 Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932